PUK16 - COST-EFFECTIVENESS OF TOLVAPTAN IN CANADIAN PATIENTS WITH AUTOSOMAL POLYCYSTIC KIDNEY DISEASE- AN ADAPTATION OF THE ADPKD OUTCOMES MODEL
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2814
https://www.valueinhealthjournal.com/article/S1098-3015(18)36116-3/fulltext
Title :
PUK16 - COST-EFFECTIVENESS OF TOLVAPTAN IN CANADIAN PATIENTS WITH AUTOSOMAL POLYCYSTIC KIDNEY DISEASE- AN ADAPTATION OF THE ADPKD OUTCOMES MODEL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)36116-3&doi=10.1016/j.jval.2018.09.2814
First page :
Section Title :
Open access? :
No
Section Order :
2164